CR-002 (CuraGen)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCR-002 (CuraGen)
Drug Alias NameCR-002
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionPlatelet-derived growth factor D antagonists
TargetsPlatelet-derived growth factor D
Therapy Area/IndicationsLupus Erythematosus, SystemicGlomerulonephritis, IGADiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCuragen CorporationAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCuragen CorporationAmgen Inc
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, SystemicGlomerulonephritis, IGADiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksDrugBank